TY  - CONF

T1  - Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2023/01/01

AU  - Siegfried E

AU  - Cork MJ

AU  - Lockshin B

AU  - Boguniewicz M

AU  - Uppal S

AU  - Vass M

AU  - Khokhar FA

AU  - Bansal A

AU  - Sierka D

AU  - Cyr S

ED  - 

VL  - 89

IS  - 3

SP  - AB62

EP  - AB62

Y2  - 2024/12/22

ER  -